Literature DB >> 25101832

Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance.

Raman Rohilla1, Tarun Garg1, Amit K Goyal1, Goutam Rath1.   

Abstract

The liver is a vital organ present in vertebrates, which performs many functions including detoxification, protein synthesis and production of various bio-chemicals which are very important for digestion. A large number of serious liver disorders affect millions of people worldwide which are very difficult to treat properly despite many efforts. There are several factors which are responsible for liver injuries, include plants (Crotalaria Senecio Heliotropium Symphytum officinale), drugs (analgesic and antibiotics), industrial toxins (mercury and lead), water, alcohol and so on. Herbal medicinal preparations can be used for the treatment of a large number of human liver disorders like cirrhosis, hepatitis, carcinomas, etc. Indian Medicinal Practitioner's Co-operative pharmacy and Stores (IMPCPS) approved herbal-based systems (Unani, Siddha and Ayurveda) for the treatment of various chronic liver disorders. Different types of the receptors are found on the surface of hepatocytes, Kupffer cell, hepatic stellate cell and sinusoidal endothelial cells, etc., which can be used for achieving liver targeting. These receptors bind to different types of ligands (galactosylated, lactobionic acid, asialofetuin, etc.) which can be used in the formulation to achieve targeted delivery of the drug. Various novel particulate approaches (liposomes, niosomes, nanoparticles, micelles, nanosuspensions, etc.) can be used to enhance the targeting efficiency of systems to receptors found on the surface of different cells present in the liver. In this review, we focused on the status of liver targeting via herbal and nanotechnology inspired formulation approaches.

Entities:  

Keywords:  Herbal approach; liver targeting; nanotechnological approach; targeted drug delivery

Mesh:

Substances:

Year:  2014        PMID: 25101832     DOI: 10.3109/10717544.2014.945018

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  6 in total

Review 1.  Bioactive Loaded Novel Nano-Formulations for Targeted Drug Delivery and Their Therapeutic Potential.

Authors:  Sapna Kumari; Anju Goyal; Eda Sönmez Gürer; Evren Algın Yapar; Madhukar Garg; Meenakshi Sood; Rakesh K Sindhu
Journal:  Pharmaceutics       Date:  2022-05-19       Impact factor: 6.525

2.  Fabrication and characterization of a novel self-assembling micelle based on chitosan cross-linked pectin-doxorubicin conjugates macromolecular pro-drug for targeted cancer therapy.

Authors:  Zhi-Ping Li; Ming-Chao Jiang; Bo Chen; Pei Gao; Sa Yang; Yu-Feng Liu; Peng-Ju Ye; Dong-Xiu He; Hong-Lin Huang; Cui-Yun Yu
Journal:  RSC Adv       Date:  2018-03-28       Impact factor: 4.036

3.  Dark Chocolate: Opportunity for an Alliance between Medical Science and the Food Industry?

Authors:  Ivan M Petyaev; Yuriy K Bashmakov
Journal:  Front Nutr       Date:  2017-09-26

Review 4.  Novel Drug Delivery Systems for Loading of Natural Plant Extracts and Their Biomedical Applications.

Authors:  Heshu Sulaiman Rahman; Hemn Hassan Othman; Nahidah Ibrahim Hammadi; Swee Keong Yeap; Kawa Mohammad Amin; Nozlena Abdul Samad; Noorjahan Banu Alitheen
Journal:  Int J Nanomedicine       Date:  2020-04-15

5.  Synthesis of glycyrrhetinic acid-modified liposomes to deliver Murrayafoline A for treatment of hepatocellular carcinoma.

Authors:  Cuc Thi Dinh; Ha Thi Vu; Quynh Thi Huong Phan; Linh Phuong Nguyen; Toan Quoc Tran; Dung Van Tran; Nguyen Ngoc Quy; Dung Thuy Nguyen Pham; Duong Thanh Nguyen
Journal:  J Mater Sci Mater Med       Date:  2022-10-04       Impact factor: 4.727

6.  A Complex Multiherbal Regimen Based on Ayurveda Medicine for the Management of Hepatic Cirrhosis Complicated by Ascites: Nonrandomized, Uncontrolled, Single Group, Open-Label Observational Clinical Study.

Authors:  Manish V Patel; Kalapi B Patel; Shivenarain Gupta; Andreas Michalsen; Elmar Stapelfeldt; Christian S Kessler
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-03       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.